|
| |
| | | 66582 | | 08.06.2018 | | AstraZeneca AG | | | | | | | | | | | | | 03.04.50. | | | | 03.04.50. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Fasenra 30 mg /1 ml | Injektionslösung in einer Fertigspritze | Injection solution in prefilled syringe (Benralizumabum 30 mg/ml) | R03DX10 | CI |
|
|
|
